4.6 Review

Mimickers of novel coronavirus disease 2019 (COVID-19) on chest CT: spectrum of CT and clinical features

Journal

INSIGHTS INTO IMAGING
Volume 12, Issue 1, Pages -

Publisher

SPRINGER
DOI: 10.1186/s13244-020-00956-6

Keywords

Computed tomography; Differential diagnosis; Coronavirus disease 2019; COVID-19; SARS-COV2

Ask authors/readers for more resources

COVID-19, caused by SARS-CoV-2, emerged in Wuhan, China in December 2019 and has become highly contagious. In addition to RT-PCR testing, chest CT is a highly sensitive diagnostic tool. Understanding the CT features of various conditions can help prevent misdiagnosis.
COVID-19 (coronavirus disease 2019) is a recently emerged pulmonary infection caused by severe acute respiratory syndrome coronavirus (SARS-CoV-2). It started in Wuhan, China, in December 2019 and led to a highly contagious disease. Since then COVID-19 continues to spread, causing exponential morbidity and mortality and threatening economies worldwide. While the primary diagnostic test for COVID-19 is the reverse transcriptase-polymerase chain reaction (RT-PCR) assay, chest CT has proven to be a diagnostic tool of high sensitivity. A variety of conditions demonstrates CT features that are difficult to differentiate from COVID-19 rendering CT to be of low specificity. Radiologists and physicians should be aware of imaging patterns of these conditions to prevent an erroneous diagnosis that could adversely influence management and patients' outcome. Our purpose is to provide a practical review of the conditions that mimic COVID-19. A brief description of the forementioned clinical conditions with their CT features will be included.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available